القيمة السوقية تغيير تاريخ
AstraZeneca USD 301.25B 13.1B 2026-03
Genmab DKK 20.48B 1.02B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
GRIFOLS EUR 3.69B 1.9B 2026-05
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Lakefront Biotherapeutics EUR 1.58B 147.61M 2026-05
Qiagen NV USD 6.43B 1.85B 2026-05
UCB EUR 46.41B 13.94B 2025-12